I have been looking at the Pharmi stocks as the minerals market is getting risky at the moment.
With BOT they are expecting FDA approval by mid 2024 or June hence commercialising Sofpironium Bromide in the US on its own. The SP should go up a fair bit maybe double on that alone.
Another one that has me on buy is SIG. They are looking to merge Priceline and their distribution network with Chemist Warehouse. It is seeking ACCC approval for the merger due 13th June. That will double down as well if it gets the tick.
Hope that helps.
PP
Sp trajectory post approval, page-2
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $1.949M | 5.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2985 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 420471 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |